Eli Lilly said it is investing another $5.3 billion in a manufacturing plant in Lebanon, Indiana, to expand the supply of its highly popular weight loss drug Zepbound, diabetes treatment Mounjaro ...
LOUISVILLE, Ky. (WAVE) - Eli Lilly and Company, a pharmaceutical company headquartered in Indianapolis, plans to investment more at the LEAP Research and Innovation District in Lebanon. That’s ...
Eli Lilly has announced a $3bn investment ... represents our single largest US manufacturing investment outside our home state of Indiana and will add to our ability to expand capacity to make ...
Eli Lilly has followed Novo Nordisk ... in the products before the end of the year, with investment projects ongoing in North Carolina and Indiana in the US. The new facility in Germany is ...
DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating on January 21.Invest with Confidence: Follow ...
In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...
Eli Lilly (NYSE:LLY) shares continued to soar this year with a YTD gain of ~34% compared to a ~25% rise in the S&P 500 (SP500), while Novo (NVO) has lost ~16%. In fact, the Indiana-based drugmaker ...
(Reuters) - Eli Lilly (LLY) said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in ... outside our home state of Indiana and will add to our ability to expand ...